论文部分内容阅读
胆囊低动力是胆囊结石形成的重要因素之一,西沙比利是一种新型全胃肠道促动力药,国内外报道治疗肠功能性运动障碍取得良好疗效。本次研究旨在观察西沙比利促胆囊动力的疗效。材料与方法63名胆囊结石患者,平均年龄37±2.1岁,均经 B超检查诊断为胆囊结石。将其随机分成安慰剂(n=20)、西沙比利Ⅰ(n=21)、西沙比利Ⅱ(n=22)3组。同时设立正常人对照组(n=20)系正常体检者,平均年龄35±4.1岁。予对照组、西沙比利Ⅰ组口服西沙比利5mg,每日3次。西沙比利Ⅱ组患者口服西沙比利10mg,每日3次。安慰剂组口服维生素 C
Gallbladder low power is one of the important factors in the formation of gallstone. Cisapride is a new type of total gastrointestinal motility drug. Good results have been reported in the treatment of intestinal dyskinesia at home and abroad. This study aimed to observe the efficacy of cisapride in promoting gallbladder motility. Materials and methods 63 patients with gallstone, the average age of 37 ± 2.1 years old, were diagnosed as gallstones by B-ultrasound. They were randomized into 3 groups: placebo (n = 20), cisapride I (n = 21), cisapride II (n = 22). At the same time set up a normal control group (n = 20) were normal physical examination, the average age of 35 ± 4.1 years. To the control group, cisapride group oral cisapride 5mg, 3 times a day. Cisapride II patients were given cisapride 10 mg orally 3 times daily. Placebo oral vitamin C